ストックスクリーナーアプリを入手
22.00
1.10%
0.24
アフターアワーズ：
22.00
前日終値:
$21.76
開ける：
$21.72
24時間の取引高:
676.46K
Relative Volume:
0.58
時価総額：
$2.81B
収益：
$2.25B
当期純損益:
$27.39M
株価収益率:
131.11
EPS:
0.1678
ネットキャッシュフロー:
$136.77M
1週間 パフォーマンス:
-2.00%
1か月 パフォーマンス:
-21.51%
6か月 パフォーマンス:
-1.74%
1年 パフォーマンス:
+6.23%
1日の値動き範囲:
$21.55
$22.25
1週間の範囲:
$21.26
$22.80
52週間の値動き範囲:
$19.53
$28.82
Privia Health Group Inc Stock (PRVA) Company Profile
名前
Privia Health Group Inc
セクター
電話
571-366-8850
住所
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, TXG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.00 | 2.75B | 2.25B | 27.39M | 136.77M | 0.1678 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-01-10 | 開始されました | Needham | Buy |
| 2024-12-16 | 開始されました | Macquarie | Outperform |
| 2024-10-11 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-22 | 開始されました | Citigroup | Buy |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 再開されました | Jefferies | Buy |
| 2024-02-22 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-06-13 | 開始されました | Evercore ISI | Outperform |
| 2023-04-12 | 開始されました | Stephens | Overweight |
| 2023-03-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-02-03 | 開始されました | Goldman | Buy |
| 2022-12-09 | 開始されました | Stifel | Buy |
| 2022-12-08 | 開始されました | UBS | Buy |
| 2022-09-07 | 再開されました | Truist | Buy |
| 2022-05-03 | 開始されました | BofA Securities | Buy |
| 2022-04-28 | 開始されました | BTIG Research | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-30 | 開始されました | Guggenheim | Buy |
| 2022-02-22 | アップグレード | Cowen | Market Perform → Outperform |
| 2022-01-03 | 開始されました | Jefferies | Buy |
| 2021-09-27 | 開始されました | SVB Leerink | Outperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-05-24 | 開始されました | Canaccord Genuity | Buy |
| 2021-05-24 | 開始されました | Credit Suisse | Outperform |
| 2021-05-24 | 開始されました | JP Morgan | Overweight |
| 2021-05-24 | 開始されました | Piper Sandler | Overweight |
| 2021-05-24 | 開始されました | Truist | Buy |
| 2021-05-24 | 開始されました | William Blair | Outperform |
すべてを表示
Privia Health Group Inc (PRVA) 最新ニュース
The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call - Yahoo Finance
Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace? - Yahoo Finance UK
Privia Health Group, Inc. (PRVA) Stock Forecasts - Yahoo! Finance Canada
Privia Health (PRVA) Q2 2026 Earnings Call Transcript - The Globe and Mail
(PRVA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Privia Health Group (PRVA) Is Down 5.2% After Q2 Beat And Higher 2026 OutlookWhat's Changed - simplywall.st
Privia Health Group (PRVA) Is Down 5.2% After Raising 2026 Revenue Guidance And Expanding Footprint - Yahoo Finance
A Quick Look at Today's Ratings for Privia Health(PRVA.US), With a Forecast Between $30 to $36 - Moomoo
BMO Capital Keeps Their Buy Rating on Privia Health Group (PRVA) - The Globe and Mail
Sei Investments Co. Cuts Stock Position in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health Group (PRVA) Stock Faces Cash Flow Questions After Guidance Lift - Sahm
Enterprise value to EBITDA forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Enterprise value to EBIT forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Privia Health Group (NASDAQ:PRVA) Stock Rating Upgraded by Zacks Research - MarketBeat
PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus - StockStory
Privia Health Group Q2 Earnings Call Highlights - MarketBeat
Privia Health Group, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PRVA) 2026-08-07 - Seeking Alpha
Privia Health Group Inc (PRVA) Stock Down 8.2% -- Now Undervalued? GF Score: 88/100 - GuruFocus
Form 8K Privia Health Group Inc For: 6 August By Investing.com - Investing.com Nigeria
PRVA Q2 FY2026 earnings call - finance.biggo.com
Earnings call transcript: Privia Health beats Q2 2026 estimates, shares fall - Investing.com Nigeria
Privia Health Group, Inc. Stock 12‑Month Price Target Cut to $31.78, Implies 33% Upside - TradingView
Privia Health Group Inc (PRVA) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised ... - Yahoo Finance
Privia Health Group Reports Q2 2026 Financial Results in SEC Form 10-Q Filing - Kalkine Media
Privia Health Group Releases Q2 2026 Financial Results - news.alphastreet.com
Privia Health Group (NASDAQ:PRVA) Shares Gap DownShould You Sell? - MarketBeat
Privia Health beats Q2 estimates, issues 2026 guidance - Investing.com
Privia Health Shares Slide After Q2 Adjusted Earnings Miss - marketscreener.com
Privia Health releases transcript of 2Q 2026 conference call - Bitget
Privia Health Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Privia Health Group, Inc. 2026: Revenue $632.63M, EPS $0.07— 10-Q Summary - TradingView
Privia Health (NASDAQ: PRVA) lifts Q2 2026 revenue, margins and expands credit line - Stock Titan
Privia Health beats Q2 estimates, issues 2026 guidance By Investing.com - Investing.com South Africa
Privia Health (PRVA) Misses Q2 Earnings Estimates - Yahoo Finance
Privia Health Group, Inc. Updates Earnings Guidance for the Full Year of 2026 - marketscreener.com
Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Privia Health reports Q2 revenue $632.6M, adjusted EBITDA $37.4M; raises 2026 guidance - TradingView
Privia Health Q2 2026 revenue rises 21% to $632.6 million - Quiver Quantitative
Privia Health (Nasdaq: PRVA) lifts 2026 outlook after strong Q2 results - Stock Titan
Privia Health Q2 revenue beats estimates, outlook raised - TradingView
Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results - The Manila Times
Privia Health Group Reports Second Quarter 2026 Results, Raises Full-Year Guidance - Quiver Quantitative
Privia Health : 2Q'26 Slide Presentation - marketscreener.com
Privia Health (NASDAQ:PRVA) Surprises With Q2 CY2026 Sales - Yahoo Finance
Earnings Flash (PRVA) Privia Health Group, Inc. Reports Q2 Revenue $632.6M, Vs. FactSet Est of $597.3M - Moomoo
Privia Health: Q2 Earnings Snapshot - AOL.com
BRIEF-Privia Health Group Q2 EPS USD 0.07 - TradingView
Press Release: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results - Moomoo
Privia Health Q2 2026 slides: 29% EBITDA growth, 25-state footprint - Investing.com Canada
Privia Health earnings in focus: Can profit rebound after Q1 miss? - Investing.com Nigeria
Privia Health Group Inc (PRVA) 財務データ
収益
当期純利益
現金流量
EPS
35.70%
6.73%
大文字化:
|
ボリューム (24 時間):